FDA applicant
Masimo Corporation
FDA records 116 decisions for Masimo Corporation (Irvine, CA) from 1997 to 2026: 114 510(k) clearances and 2 De Novo grants. Most are in product codes DQA (Oximeter) and MWI (Monitor, Physiological, Patient (Without…). Since 2016 its 510(k)s took a median of 221 days from receipt to decision, against 205 for FDA’s reviews in the same codes and years. Its devices cite 169 predicates, 126 of them its own earlier devices. 19 recalls are linked to its devices.
FDA’s records also spell it “Masimo Corp.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Masimo Corporation’s devices, and how often a recall has named them.
FDA decisions per year
3in 2025
2026 so far, outlined.
Recalls per year
2in 2026
Class I Class II/III not classified
Planning a device like Masimo Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report